News

We are moving to a new location

We are excited to relocate on Monday, March 30th to our new office located at 12230 Coit Road, Suite 130, Dallas, Texas 75251. Our phone number and fax numbers remain the same. Please inform your staff and patients we are still in the neighborhood, just down the block from Medical City Dallas Hospital.

In our efforts to better serve our patients, we have added more exam rooms and upgraded our X-ray technology. Our new location is on the first floor and no charge for parking.

We appreciate you entrusting us with the care of your patients and look forward to our continued relationships.

Dr. Miguel Hernandez, III, Dr. Ray Aronowitz, Dr. Alexander Cho, Dr. Zachary Kelley and Dr. Jon Nathanson.

North Dallas Office

12230 Coit Road, Suite 130 Dallas, TX 75251 Tel: (972)566-2663 Fax: (972)566-2866 Click here for driving directions & location map.

---

As of Oct. 6, 2014, the Drug Enforcement Administration has elected to change the status of all products that contain hydrocodone to a Schedule II category

The new rules mean that drugs like Vicodin, Lortab, Norco and Vicoprofen and their generic equivalents will be subject to the same prescribing rules as painkillers like dilaudid and oxycodone.

Telephone refills will not be allowed. You will need to schedule an appointment to see your doctor before obtaining a new prescription. This will be required every time you need a refill of a pain medication with Hydrocodone, Vicodin, Norco and Vicoprofen. Your physician may require that you have drug testing, urine or saliva, and may also require you to sign a pain contract for ongoing narcotic use. You may also be referred out to a Pain Management Specialist.

This also means that phone-in orders and fax orders will no longer be allowed for those medications. Only hand-carried orders will be considered as valid prescriptions.

Any hydrocodone prescriptions written before Oct. 6 with refills will be allowed to be filled as usual. If written on or after Oct. 6, no refills will be allowed per normal DEA schedule II rules.

This change to the status of drugs containing hydrocodone is a national change and will affect every patient regardless of the pharmacy they use and state they live in.